12 papers
Tirzepatide
12 publications — 8 trials, 3 syntheses.
Evidensgrunnlag
Hvat henda síða er bygdar á, evni fyri evni: hvussu nógv greinar, hvussu nógv eru royndir, og hvussu nýggj. Framleitt úr høstinum, so tað kann ikki víkja frá sjálvum tilvísingunum.
11 papers
GLP-1 mechanism
11 publications — 5 trials, 3 syntheses.
11 papers
Semaglutide weight
11 publications — 6 trials, 4 syntheses.
10 papers
Cardiovascular
10 publications — 3 trials, 6 syntheses.
10 papers
GLP-1 other
10 publications — 3 trials, 5 syntheses.
9 papers
Adverse effects
9 publications — 7 trials, 1 synthesis.
9 papers
Discontinuation
9 publications — 8 trials, 0 syntheses.
8 papers
Muscle loss
8 publications — 5 trials, 2 syntheses.
7 papers
Oral GLP-1
7 publications — 6 trials, 1 synthesis.
Tengt lesing
Fasting Evidence
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Metabolism Review
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Weight Loss Evidence
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep Evidence
Sleep, circadian rhythm and the wearables that claim to measure both.
Henda síða varð sjálvvirkandi týdd úr enskt. Tilvísingarnar og tølini eru óbroytt. Les upprunaliga enska útgávuna um nakað lesist undarliga. Les upprunaliga enska útgávuna